Paxlovid1 min read
WHAT YOU SHOULD KNOW ABOUT PAXLOVID AND LONG COVID
Research findings says people who took Paxlovid are less likely to have long COVID symptoms. The article was published in March 2023 in JAMA Internal…
Paxlovid1 min read
WHAT YOU SHOULD KNOW ABOUT PAXLOVID APPROVAL
Jennifer Lorenzini/Reuters The U.S Food and Drug Administration (FDA) approves Paxlovid for the treatment of mild-to-moderate COVID-19 . In a press…
Paxlovid1 min read
PAXLOVID: LOWER RISK OF SEVERE COVID IN PATIENTS WITH UNDERLYING CHRONIC CONDITIONS
Paxlovid reduces risk of severe COVID-19 in patients with chronic health condition a new study finds. The study which was conducted by researchers at…
Paxlovid1 min read
3 THINGS YOU SHOULD KNOW ABOUT PAXLOVID
Paxlovid is an oral antiviral medication for the treatment of COVID-19 . It was developed by Pfizer for the treatment of mild-to-moderate COVID-19 in…
Ready to protect what matters most?
Book a vaccination or a free consultation today — at your home, office, or an access point near you.